Critical Care

Product development with the needs of the critically ill in mind

Auralis recognises that the critical care market, with its bias towards sterile injectable products has some very specific demands for instance the need to balance the technical complexity in product manufacture with supply security, the growing requirement for increasing patient safety through “ready to administer” / “ready to use” injectable products with the need to manage the overall pharmaceutical budget.

However it is exactly these challenging demands which Auralis has the competencies and capabilities to deliver against and through our development pipeline we aim to support this key area of the Pharmaceutical market.